#91 2012 · ColaLife · Public health logistics
Medicine couldn't reach Zambian villages — Coca-Cola could, so the medicine rode along
the problem
Anti-diarrhoea kits died in the last mile that Coca-Cola crossed every day
background
Simon Berry's observation dated to his 1988 aid posting in Zambia: Coca-Cola reached every village, and medicine didn't. Diarrhoea was killing children for want of oral rehydration salts and zinc that cost pennies but died in the last mile of public-sector distribution.
ColaLife's 2012 Zambian trial shipped AidPods — wedge-shaped anti-diarrhoea kits designed to fit the unused space in Coke crates. The trial's real discovery was better than its gimmick: retailers and wholesalers would carry the kits for ordinary margin whether or not they rode in crates. The asset was never the physical crate; it was the incentive chain that moved the bottles.
what everyone would do
The standard public-health response to last-mile medicine failures was to try to strengthen the government's own distribution chain — more trucks, more clinics, more supply infrastructure through the exact public-sector logistics network that had already failed to keep rural villages stocked with anti-diarrhoea kits.
what they saw
Berry saw that a completely unrelated company had already solved the identical distribution problem — reaching every village reliably — for a different product entirely, and that what was actually worth copying wasn't the physical crate space but the underlying incentive: wholesalers and retailers who profit from moving Coke would carry anything else that offered them the same ordinary margin, whether or not it physically traveled inside the same box.
the move
ColaLife designed aid kits to travel Coke's rural distribution — first wedged in crate gaps, then, more usefully, riding the same wholesaler-retailer network and margins that moved the bottles.
why it works
Coca-Cola's rural network functions because retailers and wholesalers at every step earn a margin for stocking and selling the product, which is what actually motivates them to keep restocking remote village shops reliably. Designing a medicine kit that entered the same wholesaler-retailer relationship, sold for a normal margin like any other retail good, gave those same intermediaries the same profit incentive to carry it — meaning the kit didn't need to literally ride inside a Coke crate to benefit from the same distribution reach, only to enter the same commercial relationship. Once the trial discovered this, ColaLife dropped the gimmicky crate-filler design and simply sold the kit as an ordinary retail product through the identical rural shop network, and because that network was already self-sustaining rather than dependent on aid funding, the medicine distribution inherited the same durability.
the payoff
Kit access in pilot districts jumped; the real lesson survived the gimmick — the network, not the crate, was the asset. Design later stocked by Zambia's public system.
where it breaks
The mechanism requires a genuinely comparable existing network reaching the exact underserved population, with margin economics that can accommodate a new product profitably — a region with no strong informal retail network for any consumer good has no equivalent network to piggyback on. It also requires the new product to actually fit the retail model economically, priced and packaged simply enough for a shopkeeper to stock and sell it for ordinary margin the way they would any small consumer good; a product needing cold storage or prescription handling wouldn't transfer into an informal retail channel the same way a shelf-stable kit could. And it depends on retailers genuinely having incentive to stock the specific new product at the margins offered — if the margin is too thin relative to the shelf space or attention it demands compared to established fast-moving goods, retailers may simply not prioritize carrying it despite the network existing in principle.
what came after
The kit was redesigned as Kit Yamoyo, sold like a consumer product through the same rural shops, and eventually adopted into Zambia's public-sector supply. The transferable lesson survived the famous photo: piggyback the margins and relationships of a network that already works, not its packaging.
references
- [1]The ColaLife storyColaLife (official), 2019colalife.org
- [2]Evaluation of the ColaLife Trial in ZambiaUK Department for International Development, 2014assets.publishing.service.gov.uk